Skip to main content

Table 1 Data of the reported cases of prenatal diagnosis of pure 18p deletion syndrome

From: A case of prenatal diagnosis of 18p deletion syndrome following noninvasive prenatal testing

Gestational Age

Age

Husband’s Age

Methodology

Origin

Deletion

Prenatal Diagnostic Indications

Reference

17

39

42

Karyotype; FISH

de novo

46,XY.ish del(18)(p10pter)(tel18p-, dim D18Z1)

advanced maternal age

[9]

20

32

38

Karyotype; aCGH

de novo

13.87 Mb deletions from 18p11.21 to pter

Increased nuchal translucency (INT) (5.1 mm) and a 5.4 cm crown-rump length (CRL) at 12 weeks’ gestation

[8]

18

32

NA

Karyotype; aCGH

de novo

12.68 Mb deletions from 18p11.32-p11.21

Second trimester maternal serum screening blood test: a high risk of Down syndrome (1:20)

[8]

18

31

NA

NIPT; karyotype; SNP-array

NA

6.9 Mb deletions at 18p11.32p11.31 and 7.5 Mb deletions in 18p11.23p11.21

INT from a value of 3.3 mm for 4.8 cm of CRL at 11 + 4 weeks to 4.9 mm for 5.91 cm of CRL at 12 + 2 weeks of gestation

[8]

23

24

26

Karyotype; FISH; microarray

maternal

18 Mb deletion at 18q11.1-p11.32

A history of abnormal pregnancy, firstpregnancy ended in a miscarriage in the first trimester; lost the second pregnancy due to a hydatidiform mole; Sonography showed congenital foetus malformation, including fused cerebral hemispheres, dilatation of the cerebral ventricles, a single palpebral fissure and proboscis

[14]

24

29

33

Karyotype; FISH; CMA

NA

4.5 Mb pure microdeletion at 18p11.32–11.31

multiple fetal abnormalities: fetal semilobar holoprosencephaly, median cleft lip and palate, arhinia and tetralogy of Fallot

[15]

19

36

34

Karyotype; FISH; aCGH; qf-PCR

de novo

14.06 Mb deletion at 18p11.32-p11.21

advanced maternal age and sonographic findings of craniofacial abnormalities; Level II ultrasound at 19 weeks of gestation showed HPE and median facial cleft

[16]

13

35

NA

karyotype

de novo

46,XX,del(18)(p11.2)

a crown-rump length of 79 mm and an increased nuchal translucency thickness of 3.9 mm

[17]

  1. Note: aCGH array-based comparative genomic hybridization, FISH fluorescent in situ hybridization, NA not available (absent or unrecorded), NIPT non-invasive prenatal testing, CMA chromosome microarray assay, qf-PCR quantitative fluorescent polymerase chain reaction, INT increased nuchal translucency